XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income
Non- Controlling Interests
Balance, beginning of period at Dec. 31, 2022 $ 4,646,859 $ 1 $ 3,025,489 $ (1,137,138) $ 2,741,615 $ 359 $ 16,533
Balance, beginning of period (in shares) at Dec. 31, 2022   107,995,262          
Balance, beginning of period (in shares) at Dec. 31, 2022       51,396,923      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 426,133       425,653   480
Exercise of stock options and issuance of restricted stock units, net [1] 13,084   13,084        
Exercise of stock options and issuance of restricted stock units, net (shares) [1]   1,557,847          
Repurchase of common stock $ (3,568)     $ (3,568)      
Repurchase of common stock (shares) (109,325) (109,325)   (109,325)      
Stock compensation expense $ 12,804   12,804        
Changes in non-controlling interests of consolidated joint ventures 1           1
Balance, end of period at Jun. 30, 2023 5,095,313 $ 1 3,051,377 $ (1,140,706) 3,167,268 359 17,014
Balance, end of period (in shares) at Jun. 30, 2023   109,443,784          
Balance, end of period (in shares) at Jun. 30, 2023       51,506,248      
Balance, beginning of period at Mar. 31, 2023 4,846,546 $ 1 3,037,515 $ (1,140,706) 2,932,666 359 16,711
Balance, beginning of period (in shares) at Mar. 31, 2023   109,034,112          
Balance, beginning of period (in shares) at Mar. 31, 2023       51,506,248      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 234,905       234,602   303
Exercise of stock options and issuance of restricted stock units, net [2] $ 8,591   8,591        
Exercise of stock options and issuance of restricted stock units, net (shares) [2]   409,672          
Repurchase of common stock (shares) 0            
Stock compensation expense $ 5,271   5,271        
Balance, end of period at Jun. 30, 2023 5,095,313 $ 1 3,051,377 $ (1,140,706) 3,167,268 359 17,014
Balance, end of period (in shares) at Jun. 30, 2023   109,443,784          
Balance, end of period (in shares) at Jun. 30, 2023       51,506,248      
Balance, beginning of period at Dec. 31, 2023 5,332,286 $ 1 3,068,597 $ (1,265,097) 3,510,544 896 17,345
Balance, beginning of period (in shares) at Dec. 31, 2023   106,917,636          
Balance, beginning of period (in shares) at Dec. 31, 2023       54,211,879      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 391,075       389,730   1,345
Exercise of stock options and issuance of restricted stock units, net [3] (9,431)   (9,431)        
Exercise of stock options and issuance of restricted stock units, net (shares) [3]   703,460          
Repurchase of common stock [4] $ (198,519)     $ (198,519)      
Repurchase of common stock (shares) (3,195,288) (3,195,288) [4]   (3,195,288) [4]      
Stock compensation expense $ 11,555   11,555        
Distributions to non-controlling interests of consolidated joint ventures (424)           (424)
Balance, end of period at Jun. 30, 2024 5,526,542 $ 1 3,070,721 $ (1,463,616) 3,900,274 896 18,266
Balance, end of period (in shares) at Jun. 30, 2024   104,425,808          
Balance, end of period (in shares) at Jun. 30, 2024       57,407,167      
Balance, beginning of period at Mar. 31, 2024 5,426,168 $ 1 3,063,224 $ (1,356,746) 3,700,814 896 17,979
Balance, beginning of period (in shares) at Mar. 31, 2024   106,059,917          
Balance, beginning of period (in shares) at Mar. 31, 2024       55,703,364      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 199,914       199,460   454
Exercise of stock options and issuance of restricted stock units, net [5] 1,425   1,425        
Exercise of stock options and issuance of restricted stock units, net (shares) [5]   69,694          
Repurchase of common stock [6] $ (106,870)     $ (106,870)      
Repurchase of common stock (shares) (1,703,803) (1,703,803) [6]   (1,703,803) [6]      
Stock compensation expense $ 6,072   6,072        
Distributions to non-controlling interests of consolidated joint ventures (167)           (167)
Balance, end of period at Jun. 30, 2024 $ 5,526,542 $ 1 $ 3,070,721 $ (1,463,616) $ 3,900,274 $ 896 $ 18,266
Balance, end of period (in shares) at Jun. 30, 2024   104,425,808          
Balance, end of period (in shares) at Jun. 30, 2024       57,407,167      
[1] Dollar amount includes $22.4 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units.
[2] Dollar amount includes $8.9 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units.
[3] Dollar amount includes $5.5 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units
[4] Dollar amount includes $100.0 million of Accelerated Share Repurchases and an incremental amount related to the 1% excise tax on share repurchases.
[5] Dollar amount includes $1.5 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units.
[6] Dollar amount includes $50.0 million of Accelerated Share Repurchases and an incremental amount related to the 1% excise tax on share repurchases.